BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10533346)

  • 1. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH; Fassett WE; Christensen DB
    J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of a financial incentive on cognitive services: CARE project design/implementation.
    Christensen DB; Holmes G; Fassett WE; Neil N; Andrilla CH; Smith DH; Andrews A; Bell EJ; Hansen RW; Shafer R; Stergachis A
    J Am Pharm Assoc (Wash); 1999; 39(5):629-39. PubMed ID: 10533344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of pharmacies and pharmacists associated with the provision of cognitive services in the community setting.
    Christensen DB; Hansen RW
    J Am Pharm Assoc (Wash); 1999; 39(5):640-9. PubMed ID: 10533345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principal findings from the Washington State cognitive services demonstration project.
    Christensen DB; Holmes G; Fassett WE; Neil N; Andrilla CH; Smith DH; Andrews A; Bell EJ; Hansen R; Shafer R; Stergachis A
    Manag Care Interface; 1998 Jul; 11(7):60-2, 64. PubMed ID: 10181572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does Cash and Counseling affect costs?
    Dale SB; Brown RS
    Health Serv Res; 2007 Feb; 42(1 Pt 2):488-509. PubMed ID: 17244294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and utilization analysis of a pediatric emergency department diversion project.
    Wang C; Villar ME; Mulligan DA; Hansen T
    Pediatrics; 2005 Nov; 116(5):1075-9. PubMed ID: 16263992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription analgesic and antidepressant utilization and cost among elderly Medicaid beneficiaries before and after nursing home admission.
    Chu L; Schnelle JF; Osterweil D
    J Am Med Dir Assoc; 2004; 5(2):75-81. PubMed ID: 14984617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacy participation and claim characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007.
    Look KA; Mott DA; Leedham RK; Kreling DH; Hermansen-Kobulnicky CJ
    J Manag Care Pharm; 2012 Mar; 18(2):116-28. PubMed ID: 22380471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.
    Soumerai SB; Avorn J; Ross-Degnan D; Gortmaker S
    N Engl J Med; 1987 Aug; 317(9):550-6. PubMed ID: 3302713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Generic substitution' in New Jersey, 1979-87.
    Culkin TT; Mendell S
    Am Pharm; 1989 Feb; NS29(2):25-30. PubMed ID: 2648782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled letter intervention to change prescribing behavior: results of a dual-targeted approach.
    Collins TM; Mott DA; Bigelow WE; Zimmerman DR
    Health Serv Res; 1997 Oct; 32(4):471-89. PubMed ID: 9327814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management program.
    Carter BL; Chrischilles EA; Scholz D; Hayase N; Bell N
    J Am Pharm Assoc (Wash); 2003; 43(1):24-33. PubMed ID: 12585748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of predetermined payment rates for Medicare home healthcare.
    Brown R; Phillips B; Bishop C; Thornton C; Ritter G; Klein A; Schochet P; Skwara K
    Health Serv Res; 1997 Oct; 32(4):397-414. PubMed ID: 9327810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization and costs of medical services and prescription medications for rheumatoid arthritis among recipients covered by a state Medicaid program: a retrospective, cross-sectional, descriptive, database analysis.
    Khanna R; Smith MJ
    Clin Ther; 2007 Nov; 29(11):2456-67. PubMed ID: 18158087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streamlining antimicrobial therapy through pharmacists' review of order sheets.
    Briceland LL; Lesar TS; Lomaestro BM; Lombardi TP; Gailey RA; Kowalsky SF
    Am J Hosp Pharm; 1989 Jul; 46(7):1376-80. PubMed ID: 2757043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
    Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
    BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a Medicaid database to analyze pharmaceutical services in long-term-care facilities.
    Lipowski EE; Wiederholt JB; Kreling DH; Collins TM
    Am J Hosp Pharm; 1986 Jun; 43(6):1467-72. PubMed ID: 3088992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Washington state screening, brief intervention, and referral to treatment project: cost outcomes for Medicaid patients screened in hospital emergency departments.
    Estee S; Wickizer T; He L; Shah MF; Mancuso D
    Med Care; 2010 Jan; 48(1):18-24. PubMed ID: 19927016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.